Donate online today. €40 funds 1 hour of a research project

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

MRF welcomes US MenB applications

MRF welcomes US MenB applications

19 June 2014

Further to the news that drugs companies Novartis and Pfizer have made applications to the US Food and Drug Administration to license their meningococcal B (Men B) vaccines, our CEO Christopher Head commented:

"We welcome the news of these Men B vaccine licence applications in the US. Meningitis Research Foundation’s vision is of a world free from meningitis and septicaemia and we believe that vaccination is the way to reach our ultimate goal. In the UK we are eagerly awaiting introduction of MenB vaccine into the childhood immunisation programme and it is encouraging to see this latest progress on protecting Americans against this deadly disease"

Read more about the applications

More on MenB

In-depth Q + A on the vaccine


Laura Mittelman
Pneumococcal meningitis
Pneumococcal meningitis at 2

We tried to come to terms with the fact we would probably not leave hospital with her.

More stories